🇺🇸 bimatoprost and timolol maleate fixed combination in United States

bimatoprost and timolol maleate fixed combination (bimatoprost and timolol maleate fixed combination) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

bimatoprost and timolol maleate fixed combination in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is bimatoprost and timolol maleate fixed combination approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for bimatoprost and timolol maleate fixed combination in United States?

University of Campinas, Brazil is the originator. The local marketing authorisation holder may differ — check the official source linked above.